This event is invite only. Please email Sikeen Paroo at email@example.com with any questions.
Join the HBS Startup Studio NYC and the HBS Health Care Initiative for cocktails and a fireside chat with Aditya Julka, MBA 2009, HBS EIR and Founder of Anibim LLC, with Bernard Peperstraete, MBA 2005, President/CEO of Acuamark Diagnostics, moderated by Avani Patel, HBS Startup Studio NYC Director.
Aditya is a serial entrepreneur with a history of successful start ups in life sciences and technology. He co-founded two biotech companies in his twenties, and his last company, which was backed by Accel Ventures, sold to a publicly listed company in 2010. He was also the co-founder of Paddle8 (sold to Auctionata in 2016, forming the world's largest online auction house). He is currently working on his next project in the Biotechnology/Healthcare space as well as investing in and advising start-ups in the space. Aditya has been named to the Art + Auction Power 100, Artinfo's Global 30 under 30 and the Crain's New York 40 Under 40. He has been a featured speaker at many conferences and forums globally, including those at Harvard University, DLD New York, The Northside Festival, TechCrunch TV and the inaugural TEDx Art in New York and has written on entrepreneurship for publications like Forbes. He is interested in investment opportunities in technology and life sciences in the US and India.
Bernard is President/CEO of Acuamark Diagnostics, Inc. AcuamarkDx focuses on developing a highly accurate, affordable and scalable test for early detection of cancer out of blood. AcuamarkDx’s scientific and academic team is credited with inventing groundbreaking assays/technologies such as qPCR, LCR, LDR, zipcoding and the universal array. Prior to AcuamarkDx, Bernard served as Acting President/CEO of ACT Biotech, a cancer therapeutics company (acquired by Eddingpharm). Earlier, Bernard was involved in HC venture capital most recently as a Partner at NGN Capital. He served on the boards of Exosome Dx, ACT Biotech and Potentia Pharma (now Apellis Pharma) and was also involved in transactions such as Santhera Pharma (SANN:SIX) and Artisan Pharma (acquired by AKP). Before completing his MBA at Harvard, Bernard was a Deputy Director at the Tan Tock Seng Hospital in Singapore. Prior to TTSH, he co-founded and ran a contract research business, also in Singapore. In 1999, after serving as a physician, Dr. Peperstraete managed the HIV business unit at Bristol Myers & Squibb, Singapore, and worked on emerging market opportunities at Novartis, Basel.
Avani joins HBS with years of experience in the startup world in various capacities including as a founder, advisor, mentor and investor. Most recently she founded TrendSeeder, the first fashion-focused accelerator in NYC, which has a deep educational focus described by Women's Wear Daily as a "mini-MBA program taught by industry experts." TrendSeeder also boasts a highly curated list of over one hundred mentors recruited by Avani from the executive levels of the most highly regarded fashion companies around the world. In her work with TrendSeeder and other organizations, Avani has advised over five hundred entrepreneurs. She has also traveled the world, including to Oulu, Finland for the Midnight Pitch Fest to share her entrepreneurial expertise. Avani was also named a Role Model by Carrie Hammer and graced the company's runway at New York Fashion Week in 2015.
Prior to founding TrendSeeder, Avani had a career as a corporate attorney where she worked on multi-billion dollar mergers. However, TrendSeeder wasn't Avani's first foray into the fashion world. She founded a men's and women's contemporary clothing label when she was in law school which was featured in a fashion show at Lollapalooza.
Avani also finds the time to give back and has worked with organizations like the Tory Burch Foundation, the Girl Scouts and the Athena Center at Barnard College.